No Data
No Data
No Data
No Data
No Data
Scopus BioPharma's Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancer
DUET-102 in Combination with PD-1 Blockade Demonstrates Significant Anti-Tumor Activity in Models of Malignant Glioma Data Suggests Benefits of Combinations of DUET-102 with Other T-Cell Based Immunotherapies, such as
GlobeNewswireNov 7, 2023 09:15 ET
Scopus BioPharma's Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (OTCQB: "SCPS"), a biotechnology company developing transformational therapeutics for serious diseases with significant unmet medical need, and its
GlobeNewswireNov 2, 2023 09:15 ET
Nasdaq to Delist Shares of Waitr and Calithera Biosciences, Among Others
Seeking AlphaMar 1, 2023 18:26 ET
Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Meta
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares of EQONEX LIMITED. EQONEX LIMITED ordinary shares were suspended on Novem
GlobeNewswireMar 1, 2023 16:17 ET
Scopus BioPharma (NASDAQ:SCPS) Shares Down 8.3%
Shares of Scopus BioPharma Inc. (NASDAQ:SCPS – Get Rating) dropped 8.3% on Wednesday . The company traded as low as $0.10 and last traded at $0.11. Approximately 21,957 shares traded hands during mid
Defense WorldJan 19, 2023 01:41 ET
Scopus BioPharma Inc. (NASDAQ:SCPS) Sees Significant Increase in Short Interest
Scopus BioPharma Inc. (NASDAQ:SCPS – Get Rating) was the recipient of a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 60,400 share
Financial News LiveDec 28, 2022 18:41 ET
Will73 :
With account relating issues, you might wanna contact customer service for help.
FAQ: How do I contact customer service?
BrentATreeeOP Will73: Thank you, I appreciate your help!
TevyTevo : Yeah I can't even buy shares. Saying moomoo doesn't support I'm like wtf
No Data
No Data